OR WAIT null SECS
Patricia Van Arnum was executive editor of Pharmaceutical Technology.
April 16, 2008
Takeda Pharmaceutical agreed to acquire Millennium Pharmaceuticals for $8.8 billion in cash or $25 per share.
April 10, 2008
Schering-Plough announced a major new productivity transformation program with a goal of achieving $1.5 billion in annual savings.
April 03, 2008
US pharmaceutical and biotechnology research companies invested $58.8 billion in research and development in 2007, according to analyses by the Pharmaceutical Research and Manufacturers of America and Burrill & Company.
April 02, 2008
The former formulation-development business of MDS Pharma Services seeks to build its niche in early-phase drug development.
The economic case for personalized medicine offers a solution to the industry's recent woes.
Moderate growth is projected for the global excipients market. Excipient producers target blends and new grades for improving functionality and performance.